A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of Vonoprazan in Adolescents With Symptomatic Gastroesophageal Reflux Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 9, 2022

Primary Completion Date

May 30, 2023

Study Completion Date

June 13, 2023

Conditions
Gastroesophageal Reflux
Interventions
DRUG

Vonoprazan

Oral Tablet

Trial Locations (10)

14642

University of Rochester Medical Center, Rochester

45429

PriMED Clinical Research, Dayton

72211

Preferred Research Partners, Inc., Little Rock

78726

ARC Clinical Research at Four Points, Austin

79902

Pediatric Gastro, El Paso

92805

Advanced Research Center - Elligo, Anaheim

36604-1541

University of South Alabama (USA) Physicians Group, Mobile

30260-2342

Infinite Clinical Trials, Morrow

70072-3151

Legacy Clinical Solutions: Tandem Clinical Research, LLC, Marrero

02111

Boston Specialists, Boston

Sponsors
All Listed Sponsors
lead

Phathom Pharmaceuticals, Inc.

INDUSTRY